What is the indication for a Lasix (furosemide) challenge?

Lasix Challenge Indication

A furosemide (Lasix) challenge is primarily indicated to predict the need for renal replacement therapy (RRT) in patients with acute kidney injury (AKI), and to differentiate diuretic-responsive from diuretic-resistant patients in acute heart failure (AHF) with volume overload. 1

Primary Indications

1. Predicting Need for Renal Replacement Therapy

The furosemide stress test (FST) serves as a functional biomarker to predict which AKI patients will require dialysis. The test involves administering intravenous furosemide and measuring urine output over a defined period to assess residual tubular function. 1

• Performance: The FST demonstrates an AUROC of 0.84 for predicting KRT discontinuation and has been validated for predicting KRT need after kidney transplantation 1
• Mechanism: Patients who fail to produce adequate urine output after furosemide challenge have insufficient tubular function and are more likely to require dialysis
• Timing: This test is most useful when clinical risk scores suggest high probability of needing RRT, allowing for better resource planning and patient counseling

2. Identifying Diuretic Resistance in Heart Failure

In AHF patients with severe volume overload, an intravenous furosemide challenge (typically 80 mg IV) can rapidly separate diuretic-responsive from diuretic-resistant patients. 2

The test protocol: Administer 80 mg IV furosemide and measure urinary sodium excretion over 8 hours:

• Diuretic-responsive: ≥50 mmol sodium in 8 hours
• Diuretic-resistant: <50 mmol sodium in 8 hours 2

Clinical utility: This allows clinicians to identify patients who need second-line therapies (continuous infusion, combination diuretics, or ultrafiltration) within hours rather than days of failed oral therapy 3, 2

Important caveat: While this test can speed detection of diuretic resistance, intravenous furosemide can cause acute reduction in renal perfusion and azotemia, so repeated use should be minimized until safety is better established in randomized trials 2

Key Clinical Context

When NOT to Use Furosemide Challenge

The challenge should be avoided in:

• Hypotensive patients (SBP <90 mmHg) - unlikely to respond and may worsen hemodynamics 4
• Severe hyponatremia or acidosis - these patients are unlikely to respond to diuretics 4
• Severe renal dysfunction with oliguria - unless specifically testing for RRT prediction 1

Monitoring Requirements

When performing a furosemide challenge:

• Bladder catheter placement is usually desirable to accurately monitor urinary output and rapidly assess treatment response 4
• Frequent assessment in the initial phase to follow urine output 4
• Electrolyte monitoring for hypokalemia, hyponatremia, and changes in renal function 5

Alternative to Challenge Testing

Recent evidence suggests that 2-hour urine output assessment may be sufficient to evaluate diuretic response without waiting the traditional 6-8 hours, with strong correlation between 2-hour and 6-hour measurements (R²=0.683) 6. This allows for more rapid dose adjustments in AHF patients.

Practical Algorithm

For AHF patients with volume overload:

1. Ensure SBP >90 mmHg and absence of severe hyponatremia
2. Administer 80 mg IV furosemide (or 40 mg if diuretic-naive)
3. Place bladder catheter for accurate measurement
4. Measure urine output at 2 hours (may be sufficient) or 8 hours
5. If <50 mmol sodium in 8 hours → consider diuretic-resistant and escalate to combination therapy, continuous infusion, or ultrafiltration 3, 2

For AKI patients at risk for RRT:

1. Perform FST when clinical risk scores suggest high probability of needing dialysis
2. Use results to guide timing of RRT initiation and facilitate shared decision-making with patients and nephrologists 1